The Leadership Team at American Gene Technologies International guides the company's strategic direction and oversees the development of innovative lentivirus therapies. Comprising the CEO & Founder, Chief Science Officer, and Vice President of Clinical Development and Regulatory Affairs, the team is responsible for driving research initiatives, ensuring regulatory compliance, and fostering partnerships to advance the company's mission to provide bio-safe treatments for cancer, HIV/AIDS, and other chronic disorders.
View all